| 1 |
Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma.
61
|
Park SW...Park KH
|
33591471 |
2021 |
| 2 |
Distinguishing Features of Anterior Uveitis Caused by Herpes Simplex Virus, Varicella-Zoster Virus and Cytomegalovirus.
61
|
Terada Y...Mochizuki M
|
33773985 |
2021 |
| 3 |
Granulomatous uveitis and choroidal detachment in a patient after topical treatment with Bimatoprost: A case report.
61
|
Massimo L...Bordinone MA
|
33508974 |
2021 |
| 4 |
DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE.
61
|
Diniz LMO...Romanelli RMC
|
32876305 |
2021 |
| 5 |
Nodular anterior scleritis associated with Berger's disease.
61
|
Constancio EG...Cabral T
|
33470345 |
2021 |
| 6 |
Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
61
|
Topouzis F...Lerner SF
|
31595773 |
2021 |
| 7 |
Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects.
61
|
Bertens CJF...Gijs M
|
33384889 |
2020 |
| 8 |
Effect of Scleral Lens Oxygen Permeability on Corneal Physiology.
61
|
Dhallu SK...Wolffsohn JS
|
32932393 |
2020 |
| 9 |
Ocular Sporotrichosis.
61
|
Ribeiro CR...Lima MHC
|
32885097 |
2020 |
| 10 |
A Case of Metastatic Iris Tumor Observed With Anterior Segment Optical Coherence Tomography Before and After Radiation Therapy.
61
|
Mitamura M...Ishida S
|
32606198 |
2020 |
| 11 |
Corneal Perforation during Combination Chemotherapy including Cetuximab in a Patient with a History of Herpetic Keratitis.
61
|
Aomatsu K...Kusaka S
|
32724688 |
2020 |
| 12 |
Hemicrania Continua Subsequent to Vertebral Artery Dissection: A Case Report.
61
|
Tabata H...Kitaguchi H
|
31611169 |
2019 |
| 13 |
Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
61
|
de Oliveira JK...Montiani-Ferreira F
|
30724448 |
2019 |
| 14 |
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.
61
|
Weinreb RN...Hubatsch DA
|
30403988 |
2019 |
| 15 |
A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia.
61
|
Hsu CR...Lu DW
|
30735565 |
2019 |
| 16 |
Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis.
61
|
Liu Y...Huang Y
|
31293419 |
2019 |
| 17 |
Ocular Impression-Taking-Which Material Is Best?
61
|
Turner JM...Murphy PJ
|
29505434 |
2019 |
| 18 |
Efficacy And Safety Of Travoprost Versus Timolol To Treat Early-Onset Ocular Hypertension Secondary To Vitrectomy: A Randomized Trial.
61
|
Fang Y...Sun X
|
31686785 |
2019 |
| 19 |
A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma.
61
|
Stacy R...Grosskreutz C
|
29802818 |
2018 |
| 20 |
A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
61
|
Prasanna G...Mogi M
|
29610853 |
2018 |
| 21 |
Tivanisiran, a novel siRNA for the treatment of dry eye disease.
61
|
Moreno-Montanes J...Jimenez AI
|
29569947 |
2018 |
| 22 |
Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.
61
|
Kam KW...Young AL
|
27192186 |
2017 |
| 23 |
A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension.
61
|
Dixon ER...Feldman R
|
28887006 |
2017 |
| 24 |
[Reactive Arthritis during the Second Course of Intravesical BCG Therapy Requiring Administration of Methotrexate : A Case Report].
61
|
Ikeuchi R...Segawa T
|
28889718 |
2017 |
| 25 |
Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
61
|
Kuwayama Y...Shimada F
|
28502035 |
2017 |
| 26 |
Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: A Randomized Trial.
61
|
Barnebey HS...Robin AL
|
27993589 |
2017 |
| 27 |
Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study.
61
|
Harris A...Serle JB
|
27300645 |
2016 |
| 28 |
A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers.
61
|
Laties A...Baumgartner RA
|
27046445 |
2016 |
| 29 |
Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
61
|
Weleber RG...Stout JT
|
27102010 |
2016 |
| 30 |
Association between glaucoma eye drops and hyperemia.
61
|
Yanagi M...Fukushima A
|
26847553 |
2016 |
| 31 |
Meta-analysis of the Efficacy and Safety of Latanoprost Monotherapy in Patients With Angle-closure Glaucoma.
61
|
Chen R...Zhan SY
|
25383466 |
2016 |
| 32 |
Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs.
61
|
Lo JS...Lo SC
|
27099466 |
2016 |
| 33 |
Quantifying Ocular Surface Inflammation and Correlating It With Inflammatory Cell Infiltration In Vivo: A Novel Method.
61
|
Ferrari G...Rama P
|
26529042 |
2015 |
| 34 |
Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
61
|
Lopes JF...Amaris P
|
26563363 |
2015 |
| 35 |
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects.
61
|
Araie M...Weinreb RN
|
26563323 |
2015 |
| 36 |
Ocular risk management in patients undergoing general anesthesia: an analysis of 39,431 surgeries.
61
|
Kara-Junior N...Silva ED
|
26247665 |
2015 |
| 37 |
Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure.
61
|
Bacharach J...AR-13324-CS202 Study Group
|
25270273 |
2015 |
| 38 |
Two cases of adult-onset Still's disease with orbital inflammatory lesions originating from the lacrimal gland.
61
|
Bannai E...Mimori A
|
26466709 |
2015 |
| 39 |
Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy.
61
|
Schnober D...Scherzer ML
|
26005326 |
2015 |
| 40 |
Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension.
61
|
Sharma S...Aung T
|
26648686 |
2015 |
| 41 |
PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.
61
|
Coroi MC...Tit M
|
27373107 |
2015 |
| 42 |
Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.
61
|
Kost OA...Kabanov AV
|
26697135 |
2015 |
| 43 |
Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.
61
|
DuBiner HB...Hubatsch DA
|
25432143 |
2014 |
| 44 |
Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients.
61
|
Hollo G...Ropo A
|
24738883 |
2014 |
| 45 |
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.
61
|
de Vos S...Advani R
|
24919462 |
2014 |
| 46 |
Intraocular pressure-lowering efficacy of dorzolamide/timolol fixed combination in normal-tension glaucoma.
61
|
Kim TW...Park KH
|
23377586 |
2014 |
| 47 |
An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial.
61
|
Crichton AC...Yan DB
|
24920879 |
2014 |
| 48 |
An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and xalatan in patients with glaucoma or ocular hypertension.
61
|
Digiuni M...Rossetti L
|
22595934 |
2013 |
| 49 |
Development of automated conjunctival hyperemia analysis software.
61
|
Sumi T...Fukushima A
|
24104935 |
2013 |
| 50 |
[Effects of silicone punctal plugs for tear deficiency dry eye patients].
61
|
Shi S...Sun L
|
23714033 |
2013 |
